ThinkStock Photos has buy call on Aster DM Healthcare with a target price of Rs 270. The current market price of is Rs 210.65. Time period given by analyst is one year when . price can reach defined target.
Aster DM Healthcare Ltd., incorporated in the year 2008, is a Mid Cap company (having a market cap of Rs 10462.30 Crore) operating in Hospitals & Allied Services sector.
Aster DM Healthcare Ltd. key Products/Revenue Segments include Hospital Services, Pharmaceuticals, Other Operating Revenue, Other Services, Consultancy Income for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-06-2022, the company reported a Consolidated Total Income of Rs 2699.39 Crore, down -1.83 % from last quarter Total Income of Rs 2749.77 Crore and up 13.44 % from last year same quarter Total Income of Rs 2379.63 Crore. Company reported net profit after tax of Rs 80.16 Crore in latest quarter.
Investment Rationale
Aster DM’s reported revenues, in a seasonally lean 1Q, beat estimates by 12% (partly due to currency tailwinds) with a margin miss on account of post-Covid normalisation and new hospital losses. Although management expects 2Q to be the strongest for India business, 2H typically is 60% of full year EBITDA implying sequential improvement in margins hereon. While timelines for GCC restructuring remain elusive, any decision on the same is unlikely this year. Aster DM’s strategic India focus with consistent India outperformance can drive consensus upgrades thereby re-rating the stock.
Promoter/FII Holdings
Promoters held 37.88 per cent stake in the company as of 30-Jun-2022, while FIIs owned 11.44 per cent, DIIs 9.65 per cent.
Aster DM Healthcare Ltd., incorporated in the year 2008, is a Mid Cap company (having a market cap of Rs 10462.30 Crore) operating in Hospitals & Allied Services sector.
Aster DM Healthcare Ltd. key Products/Revenue Segments include Hospital Services, Pharmaceuticals, Other Operating Revenue, Other Services, Consultancy Income for the year ending 31-Mar-2022.
Financials
For the quarter ended 30-06-2022, the company reported a Consolidated Total Income of Rs 2699.39 Crore, down -1.83 % from last quarter Total Income of Rs 2749.77 Crore and up 13.44 % from last year same quarter Total Income of Rs 2379.63 Crore. Company reported net profit after tax of Rs 80.16 Crore in latest quarter.
Investment Rationale
Aster DM’s reported revenues, in a seasonally lean 1Q, beat estimates by 12% (partly due to currency tailwinds) with a margin miss on account of post-Covid normalisation and new hospital losses. Although management expects 2Q to be the strongest for India business, 2H typically is 60% of full year EBITDA implying sequential improvement in margins hereon. While timelines for GCC restructuring remain elusive, any decision on the same is unlikely this year. Aster DM’s strategic India focus with consistent India outperformance can drive consensus upgrades thereby re-rating the stock.
Promoter/FII Holdings
Promoters held 37.88 per cent stake in the company as of 30-Jun-2022, while FIIs owned 11.44 per cent, DIIs 9.65 per cent.
(Disclaimer: Recommendations given in this section or any reports attached herein are authored by an external party. Views expressed are that of the respective authors/entities. These do not represent the views of Economic Times (ET). ET does not guarantee, vouch for, endorse any of its contents and hereby disclaims all warranties, express or implied, relating to the same. Please consult your financial adviser and seek independent advice.
Experience Your Economic Times Newspaper, The Digital Way!
Read More News on
(What's moving Sensex and Nifty Track latest market news, stock tips and expert advice on ETMarkets. Also, ETMarkets.com is now on Telegram. For fastest news alerts on financial markets, investment strategies and stocks alerts, subscribe to our Telegram feeds.)
...moreDownload The Economic Times News App to get Daily Market Updates & Live Business News.
Pick the best stocks for yourself
Powered by